|
| |
BioPortfolio's Approved Drugs DatabaseRanexaRanolazineDownload PDF containing detailed information.
Press Releases About Ranexa:
|
 |
| CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer |
12th March, 2009 |
CV Therapeutics |
PALO ALTO, Calif., March 12 /PRNewswire-FirstCall/ -- The Board of Directors of CV Therapeutics, Inc. (Nasdaq: CVTX) announced today that after careful consideration of Astellas Pharma Inc.'s $16
|
| CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas' Tender Offer |
27th February, 2009 |
CV Therapeutics, Inc. |
PALO ALTO, Calif., Feb. 27 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) today advised its stockholders to take no action at this time in response to Astellas Pharma Inc.'s
|
| CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results |
20th February, 2009 |
CV Therapeutics, Inc. |
- 64 percent year-over-year increase in Ranexa(R) net revenue -
- Company retires more than $100 million in convertible debt in 2008 -
- Ranexa prescriptions for first week in February hit record
|
| CV Therapeutics' Board of Directors Rejects Astellas Unsolicited Proposal |
20th February, 2009 |
CV Therapeutics, Inc. |
PALO ALTO, Calif., Feb. 20 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) today announced that its board of directors has thoroughly reviewed and rejected the previously announced
|
| CV Therapeutics Statement on Unsolicited Proposal From Astellas |
28th January, 2009 |
CV Therapeutics, Inc. |
PALO ALTO, Calif., Jan. 28 /PRNewswire-FirstCall/ -- In light of an announcement made recently by Astellas Pharma Inc., CV Therapeutics, Inc. (Nasdaq: CVTX) confirmed that it had received a letter
|
This page has been viewed 25 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Ranexa across BioPortfolio, or for Ranexa Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
